Wed, May 10, 2023

Leland Gershell Maintained (VRDN) at Buy with Decreased Target to $40 on, May 10th, 2023


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-40-on-may-10th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Leland Gershell of Oppenheimer, Maintained "Viridian Therapeutics, Inc." (VRDN) at Buy with Decreased Target from $45 to $40 on, May 10th, 2023.

Leland has made no other calls on VRDN in the last 4 months.



There are 3 other peers that have a rating on VRDN. Out of the 3 peers that are also analyzing VRDN, 0 agree with Leland's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Leland


  • Serge Belanger of "Needham" Reiterated at Strong Buy and Held Target at $47 on, Monday, April 10th, 2023
  • Alex Thompson of "Stifel" Initiated at Strong Buy and Held Target at $49 on, Thursday, March 30th, 2023
  • Michael Higgins of "Ladenburg Thalmann" Reiterated at Strong Buy and Held Target at $40 on, Thursday, March 9th, 2023

Publication Contributing Sources